Enamines
MEDCHEMEXPRESS LLC (R)-Amlodipine | 103129-81-3 | MFCD06809924 | 99.5% | 408.88 g/mol | C20H25ClN2O5 | 10 MG
(R)-Amlodipine is the R-enantiomer of amlodipine, a dihydropyridine L-type calcium channel inhibitor supplied as an off-white to light yellow solid for research use. It is commonly used in pharmacological and formulation studies that require the isolated enantiomer.
- High purity (99.45%).
- Molecular weight 408.88 g/mol.
- Chemical formula C20H25ClN2O5.
- Soluble in DMSO at 100 mg/mL; ultrasonic recommended.
- In vivo formulation protocols yield ≥2.5 mg/mL solubility in listed vehicles.
- Available in small research sizes (e.g., 10 mg).
- Storage: powder -20°C for up to 3 years; in solvent -80°C for 6 months or -20°C for 1 month.
![MEDCHEMEXPRESS LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000227030.png-250.jpg)
MEDCHEMEXPRESS LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in neural differentiation research. It is a small-molecule benzamide derivative (C16H14N4O2S; MW 326.37 g/mol; CAS 1316652-41-1) supplied as a solid with documented purity and batch COA.
- Selective HDAC8 inhibitor useful for neural differentiation studies.
- Batch-specific purity reported at 99.3% (COA).
- Available as a small 10 MG solid suitable for research-scale experiments.
- Solid stable at -20°C for up to 3 years; solvent solutions require colder storage.
- Comes with COA, SDS, and product datasheet for quality and safety information.
MEDCHEMEXPRESS LLC CDK2-IN-4 | 1316652-41-1 | 99.3% | 326.37 g/mol | C16H14N4O2S | 5 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in cell biology research, including studies of neural differentiation. The product is provided with supporting documentation for purity, handling, and storage, and is available both as a solid and as a DMSO solution.
- Selective HDAC8 inhibitor for neural differentiation studies.
- Documented purity approximately 99.3% based on certificate of analysis.
- Available as a solid and as a 10 mM solution in DMSO.
- Datasheet, certificate of analysis, and safety data sheet provided for quality and safety information.
- Storage recommendations included for powdered material and solutions.
MEDCHEMEXPRESS LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.66 g/mol | C27H26F3N7O6S2 | 1 ML
PF-562271 besylate is a potent, ATP-competitive, reversible inhibitor of focal adhesion kinase (FAK) and Pyk2 used in biochemical, cell-based, and in vivo research. It is supplied as a 10 mM solution in DMSO and exhibits low-nanomolar activity against FAK and nanomolar activity against Pyk2.
- Potent inhibition of FAK and Pyk2 (FAK IC50 = 1.5 nM; Pyk2 IC50 = 13 nM).
- Supplied as a ready-to-use 10 mM solution in DMSO for in vitro assays.
- High reported purity suitable for research use (99.17%).
- Demonstrated antiproliferative activity across multiple cancer cell lines.
- Validated pharmacological effects in vivo, including inhibition of FAK phosphorylation.
MEDCHEMEXPRESS LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.66 | C27H26F3N7O6S2 | 10 MG
PF-562271 besylate is the besylate salt of PF-562271, a potent ATP-competitive, reversible inhibitor of focal adhesion kinase (FAK) and Pyk2 used in cancer research to probe signaling pathways, tumor growth, and cell adhesion. The compound is supplied as a high-purity solid for in vitro and in vivo studies.
- Potent inhibition of FAK and Pyk2 (FAK IC50 ~1.5 nM; Pyk2 IC50 ~13 nM).
- High reported purity (99.17%).
- Provided as a solid, off-white to light-yellow material suitable for handling and formulation.
- Demonstrated antiproliferative activity in multiple human cell lines.
- Used for in vitro and in vivo studies of tumor growth, signaling, and angiogenesis.
- Available in a 10 mg package for research use.
MEDCHEMEXPRESS LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.7 g/mol | C27H26F3N7O6S2 | 1 MG
PF-562271 besylate is an ATP-competitive, reversible inhibitor of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2) used as a research tool in cell-signaling and oncology studies. It exhibits potent biochemical activity (FAK IC50 ≈ 1.5 nM; Pyk2 IC50 ≈ 13-14 nM), is supplied as the besylate salt, and is available at high purity for in vitro and in vivo research.
- Potent ATP-competitive, reversible inhibitor of FAK and Pyk2.
- Low nanomolar biochemical potency for target kinases.
- Provided as a besylate salt for improved stability and handling.
- High reported purity suitable for research applications.
- Used in cellular and animal model studies of tumor signaling pathways.
EMOLECULES INC 13887-51-9 | 2-BROMO-2-METHYL-1-MORPHOLINOPROPAN-1-ONE | AstaTech | MFCD12910756 | 236.109 | C8H14BrNO2 | 97.000 | CC(C)(Br)C(=O)N1CCOCC1 | 0.25g | 206677639
2-BROMO-2-METHYL-1-MORPHOLINOPROPAN-1-ONE | AstaTech | 13887-51-9 | MFCD12910756 | 236.109 | C8H14BrNO2 | 97.000 | CC(C)(Br)C(=O)N1CCOCC1 | 0.25g | 206677639
MED VET INTERNATIONAL AmLodipine Besylate Tablets (Norvsac), 10mg, 1000ct
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Amlodipine Besylate Tablets (norvsac), 10mg, 1000ct
MED VET INTERNATIONAL AmLodipine, 10mg Tablets, 1000 Count
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Amlodipine, 10mg Tablets, 1000 Count
MED VET INTERNATIONAL AmLodipine Besylate 5mg, 90 Tablets
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Amlodipine Besylate 5mg, 90 tablets
EMOLECULES INC 14205-39-1 | METHYL 3-AMINOCROTONATE | AstaTech | MFCD00071534 | 115.132 | C5H9NO2 | 97.000 | COC(=O)\C=C(\C)N | 25g | 482916541
METHYL 3-AMINOCROTONATE | AstaTech | 14205-39-1 | MFCD00071534 | 115.132 | C5H9NO2 | 97.000 | COC(=O)\C=C(\C)N | 25g | 482916541
